As many as 40% of cancer patients receiving immune checkpoint inhibitors experience immune-related adverse events.

HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.

Longer survival was seen in those with melanoma who received programmed cell death receptor-1 or its ligand who had a low neutrophil-lymphocyte ratio.

Various types of topical therapies are effective for the treatment of periorbital dyschromia, including caffeine, growth factors, and more.

Researchers observed significant unadjusted differences by race and ethnicity across all outcomes, with the lowest odds of delayed surgery, complications, and prolonged length of stay and the lowest ...

Preterm birth is associated with lower economic and educational achievements in young adulthood. HealthDay News — Preterm birth (PTB) is associated with lower economic and educational achievements in ...

Patients with autoimmune skin diseases should avoid taking immunostimulatory herbal supplements, as usage was associated with risks for immune dysregulation.

Vidutolimod and nivolumab demonstrated activity in a phase 2 trial of patients with high-risk, resectable melanoma.

There is a negative association between travel time to tanning facilities and county-level melanoma incidence rates.

Adults with primary hyperhidrosis had an increased risk for anxiety and depression when compared with those without primary hyperhidrosis.

The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to study findings.

Expanding access to obesity medications such as GLP-1 receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually in the United States.